Over the objections of some activists, in July 2012 the FDA approved the use of Truvada as a daily HIV preventive for some high-risk populations. Harlem Prevention Center has launched a study which will evaluate if taking the drug less frequently will also be effective. Via press release: HPTN 067, also known as The ADAPT Study, is a unique study …
Read More »